Allergan picks up option for Editas' rare eye disease drug; CureGenetics bags $17M

Retrieved on: 2018-08-06 22:38:35

Tags for this article:

Click the tags to see associated articles and topics

Allergan picks up option for Editas' rare eye disease drug; CureGenetics bags $17M. View article details on HISWAI:

Excerpt

<div><b>Qiming Venture Partners</b> led the round with additional investors which included CTS Capital and Ascendin Investment. The company plans to use the ...</div>

Article found on:

View Original Article